Delzicol FDA Approval History
FDA Approved: Yes (First approved February 1, 2013)
Brand name: Delzicol
Generic name: mesalamine
Dosage form: Delayed-Release Capsules
Company: AbbVie Inc.
Treatment for: Ulcerative Colitis
Delzicol (mesalamine) is an aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.
Development timeline for Delzicol
| Date | Article |
|---|---|
| Feb 6, 2013 | Approval Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.